Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) antibody

Catalog No. ABIN7598062

The Humanized Chimeric anti-ErbB2/Her2 (Trastuzumab Biosimilar) antibody has been validated for . It is suitable to detect ErbB2/Her2 (Trastuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) antibody (ABIN7598062)

Target: ErbB2/Her2 (Trastuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ErbB2/Her2 (Trastuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ErbB2/Her2 (Trastuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Trastuzumab Biosimilar Antibody

Specificity: P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.6 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ErbB2/Her2 (Trastuzumab Biosimilar)

Target: ErbB2/Her2 (Trastuzumab Biosimilar)

Alternative Name: Trastuzumab Biosimilar

Target Type: Biosimilar

Background: P185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein

UniProt: P04626

CAS-No: 180288-69-1